Another Study Shows CV Benefits from TRT

Buy Lab Tests Online

Jinzang

Member
A ten year study found that hypogonadal men prescribed testosterone undecanoate had fewer major adverse cardiovascular events (MACE) than those who did not receive testosterone. The study also found other cardiovascular markers, such as blood pressure and heart rate imporved on TRT. The results were reported at the annual meating of the American Association of Clinical Endocrinologists. The news report says:

According to the 10-year outcomes of hypogonadal men, fewer men experienced death from a major adverse cardiovascular events (MACE) while on testosterone undecanoate treatment compared with hypogonadal men who weren't on testosterone treatment (4% vs 21.7%). The analysis included a total of 805 men with hypogonadism, defined a a total testosterone of ≤350 ng/dL. Of this group, 676 had clinically defined hypertension or a BP reading of 130/85 mmHg or higher. A total of 376 of these hypogonadal men with hypertension then elected to receive the 3-monthly testosterone undecanoate injections, while 300 men opted against testosterone therapy, and served as the study's controls.
 
Defy Medical TRT clinic doctor
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

enclomiphene
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
6
Guests online
7
Total visitors
13

Latest posts

bodybuilder test discounted labs
Top